Neurology Medical News about Diabetic Neuropathies Peripheral Nerves

Become a Member Today!
Register

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. 2008 Exclusive Survey—Earnings: Good news for primary care income

3. Medicare pay-for-reporting effort draws fire from frustrated doctors

4. Debunking Myths in the US Healthcare System

5. Doctors and the DEA Free full text

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Association of metformin, elevated homocysteine and methylmalonic acid levels, and clinically worsened diabetic peripheral neuropathy
Diabetes Care, 11/02/09

Wile DJ et al. – Metformin exposure may be an iatrogenic cause for exacerbation of peripheral neuropathy in patients with type 2 diabetes. Interval screening for Cbl deficiency and systemic Cbl therapy should be considered upon initiation of, as well as during, metformin therapy to detect potential secondary causes of worsening peripheral neuropathy.

<< Previous
Dementia and capsular genu ischemia in patients with severe...

Next >>
Indices of Kidney Dysfunction and Discharge Outcomes in...

Prevalence and Risk Factors of Somatic and Autonomic Neuropathy in Prediabetic and Diabetic Patients
Neuroepidemiology, 11/11/09 Relevance Score: 88%

Anti-ganglioside autoantibodies in type 1 diabetes
Muscle & Nerve, 10/08/09 Relevance Score: 87%

Transforming growth factor beta 1 as a biomarker of diabetic peripheral neuropathy: cross-sectional study
Journal of Diabetes and its Complications, 10/12/09 Relevance Score: 82%

Intraepidermal nerve fibre density at wrist level in diabetic and non-diabetic patients
Diabetic Medicine, 11/09/09 Relevance Score: 81%

Sensory and Motor Peripheral Nerve Function and Lower-Extremity Quadriceps Strength: The Health, Aging and Body Composition Study
Journal of the American Geriatrics Society, 10/13/09 Relevance Score: 81%